FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like Genentech's Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial February 5, 2018 Ferring Pharma Highlights Progress On Social And Environmental Goals In Corporate Social Responsibility (CSR) Review 2015-2016 April 5, 2017 Beleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package February 14, 2018
Ferring Pharma Highlights Progress On Social And Environmental Goals In Corporate Social Responsibility (CSR) Review 2015-2016 April 5, 2017
Beleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package February 14, 2018
